IFLR1000

Search results

Narrow your search

Result types
Article type
Jurisdiction
Practice area
Industry sector
Bar admission

Showing 4861 - 4870 of 8313 for "Gianni Origoni Grippo Cappelli & Partners" with applied filters

News & Analysis

Romania: Țuca Zbârcea & Asociații advises Banca Transilvania on a syndicated loan of EUR 49.5 million in the agribusiness sector

17 December 2021 by Ţuca Zbârcea & Asociaţii

African Industries Group signed a syndicated loan of EUR 49.5 million to finance the acquisition of Thames Farming Enterprises, the parent company of Agricom Borcea, Tudor 92, Concordia Agro farms and Alisa Farm Management, from Călărași County, with a total area of 13,700 hectares and a storage capacity of almost 40,000 tons.
News & Analysis

Switzerland: MLL strengthens its Competition, Corporate and M&A and China Desk competencies with the appointment of Renato Bucher, Florian Müller and Christian Rebell to the MLL partnership

16 December 2021 by MLL Meyerlustenberger Lachenal Froriep

MLL is delighted to announce that Renato Bucher, Florian Müller and Christian Rebell will become partners of the firm on 1 January 2022.
News & Analysis

Mexico: Gonzalez Calvillo acted as local counsel to Mastercard International, Inc. in the acquisition by of Arcus FI

15 December 2021 by González Calvillo

González Calvillo acted as local counsel to Mastercard International, Inc.. in the acquisition by means of a merger of Arcus FI
News & Analysis

Romania: NNDKP advises Purolite in relation to its acquisition by Ecolab

13 December 2021 by Nestor Nestor Diculescu Kingston Petersen

NNDKP has assisted Purolite Corporation and Purolite SRL in relation to the acquisition of the companies by Ecolab, as part of a broader, global acquisition process.
News & Analysis

Romania: NNDKP assists Safety Broker in the sale of an 80% stake to Unilink

13 December 2021 by Nestor Nestor Diculescu Kingston Petersen

NNDKP has assisted Safety Broker, the largest independent insurance broker operating in Romania and in the Republic of Moldova, in the sale of 80% of the company’s shares to the Unilink group, leader on the relevant Polish market.
News & Analysis

Olive trees restoration in Ancient Olympia Greece

10 December 2021 by Bahas Gramatidis & Partners

We kindly invite you to join our noble cause; the purchase of approx. 100,000 olive trees to replace the ones lost by the recent devastating fires in the surrounding of Ancient Olympia, Greece.
News & Analysis

GC advises JA Mitsui Leasing in the financing for the construction, operation, and lease of a manufacturing plant in Guanajuato, México, to be operated by Metalsa

01 December 2021 by González Calvillo

Counsel to JA Mitsui Leasing in the USD$98,000,000.00 financing for the construction, operation, and lease of a manufacturing plant in Guanajuato, México
News & Analysis

Luxembourg: Stéphanie Lhomme joins Arendt Regulatory & Consulting to enrich Arendt’s financial crime and forensic investigations offering

30 November 2021 by Arendt & Medernach

Stéphanie Lhomme has joined Arendt Regulatory & Consulting in the role of Director in order to strengthen Arendt’s advisory services offering to clients in the areas of Forensic Investigations, Anti-bribery & Corruption, and Corporate Intelligence.
News & Analysis

India: Carlyle Group’s investments in Viyash Life Sciences Private Limited, an integrated generic pharmaceuticals platform

24 November 2021 by L&L Partners

L&L Partners Law Offices advised the Carlyle Group (“Carlyle”), on setting up an integrated generic pharmaceuticals platform, known as Viyash Life Sciences Private Limited in partnership with ex-Mylan senior executive, Dr. Hari Babu Bodepudi and ex- founder of Laurus Labs, Dr. Srihari Raju Kalidindi. L&L has also advised Carlyle on all its follow-on investments into Viyash over a period of time.
News & Analysis

India: Carlyle Group’s generic pharma platform Viyash, invests in Appcure Labs and Appco Pharma LLC

24 November 2021 by L&L Partners

L&L Partners Law Offices advised the Carlyle Group on the acquisition of 100% stake of Appcure Labs Private Limited and the acquisition of majority stake in Appco Pharma LLC through its generic pharma platform, Viyash Life Sciences Private Limited.
Load more